Pulmonary Hypertension Due to Lung Disease (Disorder) research hub

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

This study is testing a new medicine, L606, for high blood pressure in the lungs (pulmonary hypertension) caused by lung scarring (PH-ILD). We want to see if L606 is safe and helps people walk further. Some will get L606, others a dummy medicine.